FDA Inspection 1180967 — Novartis Pharma Schweizerhalle Ag
The FDA completed an inspection of Novartis Pharma Schweizerhalle Ag on Aug 25, 2022 in Pratteln. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 25, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Pratteln (Switzerland)